COVID-19 vaccines for moderately to severely immunocompromised people

i

COVID-19 vaccines for moderately to severely immunocompromised people

Supporting Files Public Domain

Dec. 9, 2021
By National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

File Language:

English

Details

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
Description:

Updated Dec. 9, 2021

CDC expands COVID-19 booster recommendations to 16- and 17-year-olds. Learn more about booster shots.

People who are immunocompromised are especially vulnerable to COVID-19. Everyone, including immunocompromised people, should receive a COVID-19 vaccine primary series if they are 5 years and older as soon as possible.
Subjects:

Coronavirus Infections COVID-19 COVID-19 Vaccines Immunization, Secondary Immunocompromised Host Vaccination
Document Type:

Webpage
Name as Subject:

Janssen COVID-19 vaccine ; Moderna COVID-19 vaccine ; Pfizer-BioNTech COVID-19 vaccine ; Janssen COVID-19 vaccine ; Moderna COVID-19 vaccine ; Pfizer-BioNTech COVID-19 vaccine
Collection(s):

Stephen B. Thacker CDC Library
Main Document Checksum:

urn:sha256:d572a0428c4c3ebae9fc354fc628ade398ada269adbb82f0fe29baacaa0a6cd7
Download URL:

https://stacks.cdc.gov/view/cdc/112425/cdc_112425_DS1.pdf
File Type:

[PDF - 255.84 KB ]

immuno.html

html

File Language:

English

ON THIS PAGE

Details Supporting Files

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.